LabCorp‘s (NYSE:LH) deadline to buy DNA testing services firm Orchid Cellmark (NASDAQ:ORCH) has been extended to July 15, the third extension for the deal in the last month. The Burlington, North Carolina-based diagnostics and laboratory services company in April had announced a definitive agreement to buy Orchid in a deal valued at more than $85 million. … Continue reading LabCorp offer to buy Orchid extended to July 15; FTC still reviewing deal